Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx Inc COMMON STOCK | 1,047,557 | 1,047,557 | 0 | $68.72M | $68.98M | 75.07% | +$261.9K |
| Kymera Therapeutics, Inc.(KYMR) | 457,059 | 457,059 | 0 | $12.51M | $19.95M | 21.71% | +$7.44M |
| Seer, Inc.CL A(SEER) | 816,375 | 816,375 | 0 | $1.38M | $1.75M | 1.90% | +$367.4K |
| Xilio Therapeutics, Inc.(XLO) | 667,742 | 667,742 | 0 | $483.7K | $454.0K | 0.49% | -$29.7K |
| Carisma Therapeutics Inc | 718,332 | 718,332 | 0 | $222.7K | $281.3K | 0.31% | +$58.6K |
| Rallybio Corporation(RLYB) | 754,678 | 754,678 | 0 | $493.9K | $255.1K | 0.28% | -$238.9K |
| Sutro Biopharma, Inc.(STRO) | 175,000 | 175,000 | 0 | $113.9K | $124.9K | 0.14% | +$11.1K |
| Rapt Therapeutics Inc | 99,503 | 12,437 | -87,066 | $121.4K | $99.5K | 0.11% | -$21.9K |